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ABSTRACT 
 
A noninvasive optical method is developed to monitor rapid changes in blood 
glucose levels in diabetic patients.  The system depends on an optical cell built with a 
LED that emits light of wavelength 535nm that is a peak absorbance of 
hemoglobin.  As the glucose concentration in the blood decreases, its osmolarity also 
decreases and the RBCs swell and decrease the path length absorption coefficient. 
Decreasing absorption coefficient increases the transmission of light through the whole 
blood.   
The system was tested with a constructed optical cell that held whole blood 
in a capillary tube.  As expected the light transmitted to the photodiode increases with 
decreasing glucose concentration.   The average response time of the system was between 
30-40 seconds. The changes in size of the RBC cells in response to glucose 
concentration changes were confirmed using a cell counter and also visually under 
microscope. 
This method does not allow measuring the glucose concentration with an 
absolute concentration calibration. It is directed towards development of a device to 
monitor the changes in glucose concentration as an aid to diabetic management. This 
method might be improvised for precision and resolution and be developed as a ring or 
an earring that patients can wear. 
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CHAPTER 1 
INTRODUCTION 
 
 
Glucose is the primary source of energy for mammalian cells, controlled by 
glucagon hormone (increase blood sugar level) and insulin (decreases sugar level by 
uptake and conversion to energy). The normal plasma glucose level in human blood after 
fasting is <6.1 mmol/L or 110 mg/dL and without fasting is within the range of 6.1 
mmol/L – 7.0 mmol/L [1]. The condition of increased glucose level beyond 7.0 mmol/L or 
126 mg/dL in the blood due to insulin deficiency (Type I) or insulin resistance (Type II) 
is called Diabetes. The Type 1 diabetes is common among children of age 0-14 years but 
also  affects  other  age  group  in  smaller  percentage  
[2].  
It  is  a  condition  caused  by 
deficiency of insulin due to cell-mediated autoimmune attack on pancreatic β-cells [3]. 
 
Type II diabetes or diabetes mellitus is common among the age group 40-60 years and 
has a strong genetic component associated with it. 90% of the diabetes cases fall under 
type II. It is a metabolic disorder that is characterized with hyperglycemia along with 
disturbance in the carbohydrate metabolism due to insulin resistance 
[4].
 
Other types of diabetes are gestational diabetes and Impaired glucose tolerance 
 
(IGT) and impaired fasting glycaemia (IFG). Gestational occurs during pregnancy and 
has various physiological factors that cause the hyperglycemic symptoms 
[5]. 
It is 
diagnosed during prenatal screening. IGT occurs during the transition between normal 
and diabetic condition and are at high risk of Type II diabetes 
[6].
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Need For Glucose Sensor 
 
 
Any diabetes with hypoglycemia or hyperglycemia can lead to long term 
complications with time. The complications of diabetes vary from patient to patient and 
can affect various part of the body. Many diabetics are affected with cardiovascular 
disease, nephropathy, retinopathy, neural disorder and lower limb amputation. 
Apart from the long term effects, diabetes also leads to ketoacidotic and 
hyperosmolar diabetic comas. Deficiency of insulin causes hyperglycemia and 
ketoacidosis. In the case of diabetic ketoacidosis (DKA), due to the decrease in insulin, 
there is a decrease in glucose use and increase in release of glucose precursors and free 
fatty acids by peripheral tissues [3]. It leads to hyperglycemia, osmotic dieresis, vomiting 
and difficulty in breathing [4]. Within few hours this can become a life threatening 
condition if proper medical attention is not provided . American Council on Science and 
Health has conducted a 6 year study that proved one third of the population in Maryland 
died with DKA that was undiagnosed. This is due to lack of awareness, no regular access 
to medical care, discomfort in using invasive method to detect glucose level and absence 
of continuous monitoring of glucose. 
There has been lot of medical technologies developed over the years for diabetes 
management that includes not just glucose measurement in blood but also continuous 
monitoring of glucose to help in better medications and understanding. Thus being of 
greater importance continuous glucose monitors are being developed using various 
invasive and non invasive techniques. 
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Continuous Glucose Monitoring Sensor (CGMS) 
Diabetes is one of the challenging health problems and has been estimated to 
increase to 21% of the US adult population in 2050 
[7]. 
Diabetes is one of the most 
common chronic diseases and is projected to be 7
th 
leading cause of death in 2030 by 
WHO. Along with the increasing percentage of diabetic patients, research on glucose 
sensor has also been developing over 50 years. International Diabetes Federation has 
reported in 2012 that 50% of the people with diabetes are left undiagnosed. These alerted 
 
the researchers for years to thrive in developing patient-friendly self monitoring blood 
glucose sensor (SMBG) and inexpensive sensors with high precision to be accessible to 
all population and be used without any discomfort. 
Blood glucose meter provides a single snapshot of the present glucose level. This 
helps in monitoring glucose at a time point but not over a period of time to follow the 
trend of changes in glucose concentration in the blood in relation to the daily activities 
like food habits, physical activities and medication. Also the sudden changes of glucose 
level during sleep or normal activities cannot be monitored. Studies over years have 
proved that 55% of hypoglycemic events occur during sleep and are also asymptomatic 
due to altered counter regulation. Also SMBG are not preferred by most patients due to 
poor compliance and inconvenience and common patients of Type I diabetes is children 
who seldom needs to use the finger pick method. 
CGMS helps in monitoring the trend of glucose level in the blood even during 
nocturnal sleep and gives deeper insight for appropriate medication for Type I diabetes 
patient, who are mostly unaware of the sudden changes of glucose level. Also help in 
providing timely medication during DKA and hypoglycemia which need continuous
4  
monitoring. The data about the magnitude, direction, duration, frequency and the 
causes of fluctuation is not provided by the intermittent glucose sensors 
[8] 
that remain 
crucial for insulin therapy. 
The need for self monitoring of glucose in diabetic patient has increased as 
research groups like Diabetic control and complication trial research group 
[9] 
proved tight control of blood glucose helps in slowing down the progression of 
micro vascular complications and long term complications related to retinopathy, 
nephropathy and neuropathy by 60%. CGMS can also be used in real time with 
patients who are critically ill and maintain a close looped control of glucose 
[10]. 
Thus 
CGMS is not only helpful in detecting hypoglycemia, it also helps in improving 
therapeutic management and reduce hypoglycemic occurrence 
[11].
 
The Development of close loop CGMS has been going on for two decades, where 
system measures glucose level at regular internal and administer insulin or glucagon 
as required. The first CGMS was developed and commercialized in 1977 by Miles 
Laboratory Inc., USA called Biostator which was able to maintain near-normal 
glucose homeostasis [
12]. 
This was a bulky device that continuously drew venous blood 
from the patient and measures the glucose level. 
Another successful product was CGMS, Medtronic MiniMed (USA) that 
was commercialized in 1999 and was able to store data of three days 
[13]. 
It had an 
electrochemical sensor, which was inserted into the subcutaneous tissue. This sensor 
was connected to a portable data processing unit by a lead and stored data every 5 
min. The system has to be calibrated with SMBG at least four times a day. 
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There have been improvisations made on these technologies for better close loop 
control. But the sensitivity of the sensor has not reached 10% of the Clarke’s error grid. 
These are being mainly designed for usage in ICU for critically ill patient. Hence 
outpatient monitoring is not possible. It has failed to display satisfactory results in 
reliability and accuracy along with an issue of time lag of 15 – 30 min. So far the systems 
developed are either invasive or minimally invasive, which can cause other risk factors 
and non compliance by patient. 
 
 
 
Contribution of the thesis 
 
The goal of the thesis is to develop a continuous glucose monitoring system that is 
completely non-invasive which patient can use outside hospitals for monitoring glucose 
level during normal day-to-day activities. It is based on photometric technique which 
uses LED of wavelength 535 nm and a photodiode sensitive to that wavelength. It is 
designed to be commercialized in future to be a worn as a finger-ring or ear-ring without 
causing discomfort during normal activities but monitoring every change in blood 
glucose level throughout the day. This system, though not capable of measuring accurate 
glucose concentration, its main purpose is to detect the sudden changes of glucose 
concentration in blood that can lead to hypoglycemia or hyperglycemia in diabetic patient 
and alarm them for medical attention or trigger insulin injection in case of hypoglycemia. 
This can be an effective continuous monitoring system for Type 1 Diabetes 
patients and would be a great assistance for insulin therapeutic management. But this 
system is not limited to Type I diabetes patients, as Type II diabetic patients also need 
monitoring to help in studying the pattern of blood glucose level changes during their 
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daily activities. It can be a useful tool in developing a healthy lifestyle by maintaining the 
glucose level around the normal level and patient can be stress free from worrying about 
the sudden changes in glucose level, where monitoring or knowing the glucose level is 
not feasible. 
This system can respond to the changes of glucose concentration in real-time, 
which gives the patient enough time to respond and get medical care. It is a simple device 
that can be made affordable to all patients and an easy to use technology. This work is 
focused on developing a technique for a product that is convenient and a patient can wear 
without developing other side effects or health hazards like skin irritation, allergic 
reaction or immune response. This system can also be used as a primary technology upon 
which sophisticated techniques can be adopted for high precision and improved features. 
Some of the features include alarm system, insulin injection and data storage. 
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CHAPTER 2 
BACKGROUND 
 
 
Why Non-Invasive technique? 
 
There are three major types of glucose measuring systems: invasive, minimally 
invasive and non-invasive measuring systems. Most widely used and developed 
technique is the invasive needle-type technique or implanted sensors as it gives 1% 
accuracy and is dependable. The invasive system can be continuous or intermittent. The 
continuous monitoring comprises of a biosensor that is implanted on the patient and the 
data is continually collected externally. The intermittent method is the traditional finger 
prick method. In the ICU blood is drawn at regular interval and the glucose level is 
tested. There are also self monitoring systems available that can be used by patients at 
home by drawing a small amount of blood from the finger and dropping it on an 
electrochemical sensor. This is stuck into a small device with a monitor that displays the 
glucose concentration. These are accurate devices but does not allow for nocturnal 
monitoring which is essential for maintaining near normoglycaemia. 
Similarly, the implantable sensors have the drawback of functional loss of 
detecting glucose 
[14]. 
Koschwanez et al 
[15] 
developed methods for testing the 
biocompatibility of these biosensors. The functional loss can be due to the histological 
changes like inflammatory reaction, fibrous encapsulation that takes place on the tissues 
around the implants. The fibrous encapsulation restricts the diffusion transportation of 
glucose to the sensor and thus reducing sensitivity 
[16-18]
. The stability of glucose sensor 
was tested by Rebrin et al and reported instability in measurement and loss of sensitivity. 
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This was supported by similar results by other researchers 
[19-21]
. Some of the risks of 
these implants are tissue injury and initiation of foreign body reactions due to long time 
interaction between the device and body. Apart from these factors, the glucose diffusion 
to the sensor is also affected by absorption of nonspecific protein from the tissue fluid 
[19-
 
21]
.   Hence   the   challenge   still   remains   for   stability   and   sensitivity   along   with 
 
biocompatibility for these invasive techniques 
[14]
. 
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Figure 1. Overview of measuring techniques of blood glucose 
[22]
. 
 
 
 
For the Minimally invasive technique, the glucose concentration is measured in 
the sub-cutis or interstitial fluid of skin. The sensor is placed in contact with the tissue or 
through iontophoresis the interstitial fluid is extracted to the sensor.   The advantage of 
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this technique is accuracy and specificity 
[23]. 
But it has a latency period of 8-15 minutes 
which encompass the sensor reaction time, signal-processing delays, and ISF-to-plasma 
glucose equilibration time. There are also other risks like infection at the site of sensor 
installation on tissue, inflammatory reaction and skin irritation as the interstitial fluids are 
being dragged across the skin. 
These risks are of great concern to the physician and the patient who use it. Hence 
the non-invasive sensor research has become a topic prime importance, influenced by the 
acceptance rate of the type-1 diabetes patients and advantages of reasonable 
biocompatibity and painless technique thus increasing the compliance by patients in 
glucose management. 
 
 
 
Photometric Techniques 
 
There are various non-invasive techniques to detect blood glucose. But widely 
researched technique is photometric or optical glucose sensor. Some of the methods 
developed are Impedance spectroscopy, ultrasound technology, thermal emission 
spectroscopy, ocular spectroscopy, electromagnetic sensing, fluid harvesting, thermal 
emission spectroscopy and photometric technique. 
Depending on the wavelength used, different methods have been studied to 
measure the concentration of blood glucose. The NIR spectroscopy, mid IR spectroscopy, 
Optical coherence Tomography, Temperature modulated localized reflectance, Raman 
spectroscopy, polarization changes and fluorescence spectroscopy are the optical 
techniques studied so far to measure glucose concentration in blood. Basically, light 
beam is directed through the skin and the properties of the light emitted is measured. 
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There is change in the property of the incident light and reflected light due to direct 
interaction with glucose or the indirect effects induced by glucose. 
The NIR (Near infrared) spectroscopy uses a light of wavelength 750-2500 nm 
that can penetrate up to 100mm depth 
[24]. 
The light is either transmitted through or 
reflected by the tissue containing glucose and the resulting light beam is altered by the 
changes in glucose concentration. The change in glucose concentration causes changes in 
the absorption and scattering coefficients that can be detected and correlated with the 
glucose concentration. Similar to this method is for mid IR expect the penetration is only 
few micrometers 
[25] 
hence only the scattered light is considered. A light of wavelength 
2500-10,000 nm is used that responds better to glucose changes than NIR. 
A low coherent light is used in the Optical coherence Tomography that is 
backscattered by the tissue which is combined with the reference light and the delay 
correlation is measured. As glucose concentration increases the refractive index also 
increases thus decreasing the mismatch of refractive index with the reference. This is 
similar to light scattering technique 
[26].
 
The tissue refractive index changes with temperature that is dependent on the 
 
glucose  concentration.  This  theory  is  used  as  the  basis  for  temperature  modulated 
localized reflectance at 590nm and 935 nm to estimate glucose concentration. 
The Raman spectroscopy is based on the theory that laser light causes oscillation 
of solutes that influence the scattering of light depending on the concentration 
[27, 28]. 
This 
helps in measuring glucose concentration with less overlapped spectra. 
The polarization technique is based on the phenomenon that the polarized light 
rotates  when  passed  through  optically  active  solutes  like  glucose  through  an  angle 
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proportional to the concentration of the solutes. It has the advantage of using visible light 
and ability to be miniaturized 
[29]
. 
In the fluorescence technique, the glucose solution when excited at 308 nm emits 
fluorescence intensity at 380 nm that is dependent on glucose concentration 
[27]
. 
Most of the photometric techniques mentioned above uses infrared or ultraviolet 
wavelength that might be harmful to the skin causing skin pigmentation, redness 
[30] 
and 
are not recommended or continuous exposure. The technique developed here is to choose 
a wavelength sensitive to glucose changes in the visible range thus being safe for 
continuous monitoring. 
The technique developed in this thesis is based on the osmolarity property of the 
RBC in response to the glucose concentration changes in the blood. 
 
 
 
Osmosis 
 
Osmosis is a phenomenon in which the water molecules pass through a 
semi-permeable membrane along a concentration gradient. The water molecules diffuse 
from region of high water concentration to low water concentration. There is a semi- 
permeable membrane that separates two sugar solution of different concentration. In the 
figure, a solution with high water concentration and less sugar concentration is in the 
right side and a solution with low water concentration and high sugar concentration is in 
the left side. Hence the water molecule tends to move from left to right to achieve 
equilibrium. The net transfer of the water becomes zero when the back pressure ‘P’ 
equals to the relative osmotic pressure, until which the fluid level rises. 
P=ρgh 
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Where, g is gravity at the surface of overlaying material 
ρ is density of liquid 
h is height of liquid column or depth within a substance 
 
 
 
 
 
 
Figure 2. Demonstration of Principle of Osmosis 
[31]
 
 
Osmosis is an important phenomenon that takes place in cell to maintain 
equilibrium with their environment. It also helps in the transport of molecule in and out 
of the cell based on the concentration gradient. 
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CHAPTER 3 
THEORY 
 
 
Osmolarity of RBC 
 
Osmosis is the phenomenon that takes place in the Red Blood Cell (RBC) with 
respect to change in the glucose concentration in the blood plasma. Osmolarity is one of 
the important properties of RBC that affects the optical property. As the glucose 
concentration increases in blood, the water molecules from the cells tend to diffuse 
outside, thus shirking the RBC cell. Similarly, as the concentration of blood glucose 
decreases, the water molecule tend to diffuse inside the RBC causing it to swell. 
 
 
100 mOs 200mOs 300mOs 400mOs 500mOs 
Hypotonic  Isotonic  Hypertonic 
 
 
Figure 3. Change in size of the RBCs in different osmolarity solution 
[32]
. 
 
The figure shows the changing size and shape of the RBC with varying 
osmolarity of blood serum. As the glucose concentration increases the RBCs shrink in 
size. The characteristic shape is called as spinocytes. But at 100mOs, there are lots of 
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ghost cells found as the cells swells to a spherical shape by the diffusing water inside and 
might rupture eventually. 
The osmolarity variations not only change the shape and volume of the RBCs, but 
also the inner cell concentration 
[32]
. The changes in RBC cause changes in optical 
property like refractive index, absorption, scattering and transmission of light. 
As the osmolarity increases the absorption coefficient of RBC is also known to 
increase 
[33]. 
As the glucose concentration increases, the cell shrinks and the absorption 
coefficient increases. Thus more light is being absorbed and the transmitted light 
decreases. Similarly as the glucose concentration decreases, the cells expand and 
absorption coefficient decreases. This causes the RBCs be a poor absorbing medium and 
thus transmit more light. Hence the transmitted light increases with decreasing glucose 
concentration. 
Apart from absorption coefficient, the scattering coefficient and refractive index 
also increases with increasing glucose concentration. The change in cell volume and cell 
shape has drastic influence on the optical properties. It has been predicted that for a 
0.05% decrease in scattering coefficient, there is a 0.1%/mM change in glucose. In 
another test, 2.1% decrease in scattering coefficient was observed for an increase of 
3.6mM of blood glucose concentration 
[34]
. 
 
Considering the optical properties of the whole blood, it is similar to the changes 
as in single RBC because absorption takes place within the cells and the red blood cells 
are highly concentrated during flow condition 
[35]
. 
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Spectral Analysis of RBC, Hemoglobin, water and tissue at 540nm 
 
 
 
 
 
 
Figure 4. Absorption coefficient of flowing RBCs of a hemoglobin solution 0.27 g/dL 
compared to values calculated by Mie theory and to data from literature 
[35]
. 
 
 
Figure 5. Absorption coefficient of flowing RBCs of a hemoglobin solution 12.9 g/dL 
compared to values calculated by Mie theory and to data from literature 
[35]
. 
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From the figure 4 and 5, it is clear that there is a maximum absorption peak at 
540nm for oxygenated hemoglobin. 
 
 
Figure 6. Spectral Absorption of oxygenated and deoxygenated hemoglobin 
[36]
. 
 
From figure 6, we can see that the absorption of oxygenated and deoxygenated 
blood is same at 540 nm. This is called as isosbestic point. Isosbestic point is the 
wavelenght at which two different species have the same molar absorptivity or it is 
linearly related. 
It can be infered from figure 7, that the absorption of water is minimal at 540 nm. 
This helps in the non interference of the water molecule in the absorption spectrum for 
RBC. But considering the spectral transmission of the tissue and skin, it is very low. Here 
is a challenge in transmiitting the light deep enough to penetrate through the tissue to 
monitor changes in the RBC absorption. 
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Figure 7. Spectral Absorption of water 
[37]
 
 
 
 
Figure 8. Spectral Transmission of tissue 
[38]
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The tissue’s optical property changes with the varying glucose concentration. The 
scattering coefficient of tissue depends on the mismatch between the extracellular fluid 
(ECF) and intracellular fluid (ICF). Increase in glucose concentration increases the 
refractive index of the ECF 
[34]
. 
Changes in glucose concentration cause change in the optical properties of 
RBC,hemoglobin and tissues. These effects can be monitored in the visible range. 
These changes are tried to be monitored in 535 nm light in this thesis. 
 The experimental strategy of this research is to use a spectrophotometer to 
calibrate the performance of a miniature optical call that can accept small quantities of 
rodent blood. The cell illuminated volume is much smaller than the spectrophotometer, 
leading to relatively poor resolution in the spectrophotometer. The constructed optical cell 
is calibrated using a red dye prepared from red food color and distilled water. Then the dye, 
prepared in different concentration, is introduced into the capillary tube and absorbance 
readings at the 535nm wavelength are taken in the spectrophotometer. This reading is then 
used as reference for calibration of the optical cell in terms of absorbance.   
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CHAPTER 4 
EXPERIMENTAL PROCEDURE 
 
 
Blood sample collection. 
 
The blood sample used in this research is taken from rodents. The blood is 
drawn from the saphenous vein. The back of the leg is shaved until the saphenous vein is 
visible. The vein is made to bulge out by compressing at the base of the leg and is 
punctured with a needle. A heparinized capillary tube is held against the droplet on the 
skin until sufficient volume is extracted through capillary action into the tube. The 
capillary tube is capped with clay. The sample is transported to the experimenting 
location within 10-20 minutes. It is stored in the refrigerator if needed to be used later. 
 
 
 
RBC under microscope 
 
Few drops of the blood sample collected are placed on a slide and diluted with 
sterile Phosphate Buffer Solution (PBS). The blood sample is also diluted with glucose 
solution of different concentration. It is smeared with another microslide by placing the 
slide at an angle and slide it across the blood sample to form a thin layer. A cover glass 
is placed over the blood sample to prevent it from drying. Then the smeared slide is 
placed under the microscope and viewed under a 50X objective lens. Once adjusted for 
focus, it is viewed in the camera attached to the lens and pictures of the view is 
snapped and stored using QCapture Pro software. 
Different concentration of glucose was prepared from stock glucose of 19.5 mM 
concentration. 
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RBC in Cell Counter 
 
Invitrogen Countess® Automated Cell Counter was used for this experiment. This 
machine has the advantage of comprehensive and reproducible data with convenient data 
archiving.  It measures the cell count and viability accurately using trypan blue. 
 
 
Figure 9. Invitrogen cell counting chamber slide with trypan blue 
 
The blood collected in the heparinized capillary tube was diluted 10000 times. As 
the RBC was densely packed, it was difficult for the cell counter to count cells. Hence 
t h e  s a m p l e  was diluted with Phosphate Buffer Solution (PBS) to decrease the 
number of red blood cells to be within the counting range of the cell counter. Then 
g l u c o s e  solution of concentration 2.5 mMol and 5 mMol was added to the diluted 
blood. Though initially PBS was used, due to the dilution, there were lot of ghost cells 
found. Hence the blood was later diluted with different molarity glucose solution itself. 
10µL of diluted blood was then pipetted along with 10µL of trypan blue dye on to 
a petri dish and mixed well. Then 10 µL of the mixed solution was pipetted into the cell 
counting chamber slide.  The  cell  counting  machine  counts  the  cell  and  its  average 
diameter in 4 µL solution in the center of the chamber slide. 
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The same experiment was repeated for different glucose concentration and the 
diameter of the cells was noted. 
 
 
 
Optical Cell 
 
A device was designed to find the absorbance as a function of voltage. An 
LED was selected to emit at the wavelength sensitive to the RBC absorbance and 
suitable to measure the changes in glucose concentration based on the theory. Hence an 
LED emitting at dominant wavelength of 535nm was used. The LED is a 1 watt power 
with a maximum forward voltage of 4 Volts. 
 
 
Photodiode 
 
 
 
 
 
 
 
 
Capillary 
tube slot 
 
 
 
 
 
LED 
 
 
 
Figure 10. Optical Cell 
 
A photodiode was used that is sensitive to green light. Function generator 
Tektronix AFG310 was used to produce a square wave at 40Hz and 200Hz with 
amplitude of 4V. LED was powered by Tektronix PS280 power supply. The output of 
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the diode was connected to single-ended signal input of the Lock-in amplifier SR530. 
Lock- in allows to detect the output of the photodiode that has frequency equal to the 
reference frequency of the Lock-in. The dynamic reserve of the Lock-in amplifier was 
set to Low as the voltage measured is in mV. 
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Figure 11. Experimental set up of the Optical cell 
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The function generator is connected to the constant current source circuit to power 
the LED and emit light at the set frequency. The function generator frequency is also 
connected to the reference of the lock-in amplifier. The LED and photo detector are 
encapsulated in a black holder of dimensions 1”x1”x0.5”, that has a slot to insert a 
capillary tube. 
The system is waited for stability for 30-40 seconds. The capillary tube is inserted 
into the slot and the data from the Lock-in amplifier is noted for every 30 seconds. 
Glucose concentration of the blood is tested prior to the test and at the end of the 
experiment using TRUEtrack® blood glucose meter. 
To increase the glucose concentration, a dialyzer fiber was introduced into the 
capillary tube with blood. The dialyzer fiber is inserted into a needle with a syringe filled 
with 10 mM glucose concentration. The syringe is operated with a syringe pump for 
constant flow of glucose through the dialyzer fiber. 
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CHAPTER 5 
VERIFICATION AND OPTIMIZATION 
 
 
 
The system has been verified for stability and repeatability of results. The 
optical cell is being calibrated against the spectrophotometer. Hence the absorption can 
be calculated from the voltage output reading from the lock-in amplifier based on the 
calibration curve. 
 
 
 
Constant current Source 
 
The LED used for the optical cell is a high efficient light source emitting at 535 
nm. The optical cell system depends on the amount of light that is transmitted through the 
capillary tube on to the photo detector. As the output result depends on the light emitted, 
it is of prime importance for the LED to emit constant output, hence can detect the actual 
changes. If the LED output varies with time and temperature, the output readings are 
erroneous. 
 
 
 
LED was tested for changes in output with time. The general theory is that, LED 
gets heated up with time. As the LED gets warmer, it draws more current and thus 
increasing the light output. In an open environment the LED is fairly constant because the 
heat is able to dissipate quickly into the environment. Figure 1 shows that the current 
drawn by the LED is steady. 
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Figure  12.  Graph  representing  the  time  Vs  current  drawn  by  the  LED  at  room 
temperature. 
 
 
 
Table 1. Tabulation of response of photodiode and current drawn by LED with time. 
 
Time (min) Temperature ◦C Current drawn by 
 
LED (mA)±0.01 
Photodiode 
 
Output (mV)±0.3 
0 24.9 24.15 362.7 
10 24.9 24.16 361.8 
20 24.9 24.16 361.1 
30 25 24.17 361.1 
40 24.8 24.17 361.1 
50 24.8 24.17 361.2 
60 24.9 24.17 361.3 
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But in a closed or isolated environment and with a source of heating, it was 
observed that the LED was drawing more current. With increasing temperature, the 
current that was drawn by LED also increases. For every 1 ◦C, the current increases by 
0.04 mA approximately. Even the small difference in the current is crucial as the changes 
to be observed are minimal and accuracy is important. 
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Figure  13.  Graph  representing  the  time  Vs  current  drawn  by  the  LED  at  varying 
temperature in an isolated environment without constant current source. 
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Table 2. Tabulation of response of photodiode and current drawn by LED at varying 
temperature in an isolated environment without constant current source. 
 
Temperature ◦C Current drawn by LED 
 
(mA)±0.01 
Photodiode Output 
 
(mV)±0.3 
24.6 24.17 367.7 
27 24.27 370.5 
28 24.29 371 
29 24.32 371.6 
30 24.36 372 
31 24.39 372.8 
32 24.43 374.2 
34 24.49 374.7 
35 24.52 375.8 
37 24.55 376.1 
39 24.62 377 
41 24.74 377.5 
 
 
To stabilize the optical cell, a constant current source is implemented. The circuit 
was adopted from the circuit design developed by Dan Goldwater. The system is 
observed to be 90% efficient and has a wide operating voltage from 3V to 30V. It is 
designed to maintain a constant current at any environmental condition that the LED is 
subjected to. 
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The circuit has a NFET and NPN transistor to control the current that drives the 
LED. The VDS controls the voltage across the drain and source of NFET and draws 
current from the source. As the VDS increases, the drain current ID increases till it reaches 
the peak voltage VP. ID reaches the maximum. As the voltage increases the drain current 
also increases. This increases the resistance of the conductivity channel, meaning the 
depletion layer grows. With maximum current, VDS is equal to VP and VGS is zero. But by 
increasing VGS, the depletion layer increases narrowing the conducting channel with zero 
current. 
The NFET IRFBG20 used in the circuit has the advantage of fast switching and 
easy driving requirements. It has wide operating range and low thermal resistance. The 
NPN transistor MJE3055T is a power switching circuit. The resistor R1 is used to protect 
the transistor as it can be easily damaged. 
In this circuit the LED current is set by R2 value. The LED is driven by 5 mA 
current and the power dissipated by the resistor is approximately 2.5 mA. 
This circuit is efficient than the LM317 voltage regulator which has only 80% 
efficiency in providing constant current to drive the LED. There is no gate current as 
JFET depends on the VDS, so less gain. It has high input impedance, hence high power 
transfer. 
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Figure 14. Circuit diagram of constant current source. 
 
 
After implementing the constant current source, the performance of the system 
was stable over a wide range of temperature. In an isolated environment with increasing 
temperature, the current drawn by LED was more stable. For every 1◦C temperature 
increase, there was a change of 0.005mA.  
The temperature of the LED was monitored using a RHXL3SD handheld 
thermometer hygrometer data logger from Omega which measures using thermocouple. 
It has an accuracy of ±0.8°C. 
There are tradeoffs in selecting the current for LED. High current, in theory, 
improves the SNR, however causing heating of the LED and sample because it is in such 
close proximity.  In this work 5V on the LED resulting in about 18.5 mA of current was 
preferred to minimize the heating effect.
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Figure  15.  Graph  representing  the  time  Vs  current  drawn  by  the  LED  at  varying 
temperature in an isolated environment with constant current source. 
 
 
 
Table 3. Tabulation of response of photodiode and current drawn by LED at varying 
temperature in an isolated environment with constant current source. 
 
Temperature ◦C Current drawn by LED 
 
(mA)±0.01 
Photodiode Output 
 
(mV) ± 0.3 
26 11.06 345.2 
27 11.07 346 
28 11.07 346 
29 11.08 347 
31 11.08 347.1 
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33 11.09 347 
36 11.1 348.2 
38 11.1 348.3 
40 11.1 349 
43 11.1 349 
 
 
 
 
Calibration Curve 
 
The optical system was calibrated against the spectrophotometer using 
solutions that were prepared in varying concentration from red dye food color (Safeway 
Inc). For calibration in the spectrophotometer, a special cuvette was designed to hold a 
capillary tube as a capillary tube is used in the optical cell. This is because of the 
change in the path length. It is based on the Beer-Lambert law. 
A = εlc 
 
Where A is the absorbance 
 
ε is the molar absorptivity constant 
l is the path length 
c is the concentration 
 
The equation shows that the absorbance depends on the path length also. As the 
path length increases, there is more solution in the path to travel by the light. More 
solution equals to more molecules that absorb the light. This makes the solution darker 
and increase the absorbance. As path length increases the absorbance increases. Also by 
increasing the concentration, the absorbance increases and appears darker. 
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To demonstrate this law, red solutions was prepared with different concentration 
with different volume of red food color and distilled water. 
 
Table 4. Tabulation of spectrophotometer reading of absorption and transmission% in 
cuvette and capillary tube. 
 
Volume of 
 
H20 in µL 
volume of 
 
red dye in 
Cuvette 
 
 
 
Absorption Transmission 
Capillary Tube 
 
 
 
Absorption Transmission 
 µL  %  % 
 
2998 
 
2 
 
0.112 
  
 
77.3 
 
0.694 
 
20.2 
 
2996 
 
4 
 
0.746 
   
17.8 
 
0.797 
 
16.4 
 
2994 
 
6 
 
1.109 
   
7.8 
 
0.83 
 
14.8 
 
2992 
 
8 
 
2.164 
  
 
0.7 
 
0.982 
 
10.4 
 
2990 
 
10 
 
2.492 
   
0.3 
 
1.061 
 
8.8 
 
2988 
 
12 
 
2.61 
  
 
0.2 
 
1.215 
 
6.1 
 
 
From the table it is clear that there is a difference in absorption compared to the 
reading in the cuvette and capillary tube. Hence was designed a capillary tube holder for 
the spectrophotometer. The holder was 3D printed to the dimensions of a cuvette 
0.49”x0.49”x1.71”. A hole was extruded along the length to fit in the capillary tube. A 
slot was then extruded for the light in the spectrophotometer to pass through. As the 3D 
printed material was white, the holder was spray painted with flat black paint. Any light 
that is reflected or scattered by the curvature of the tube can be absorbed by the black 
paint. 
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Figure 16. Capillary Tube holder for Spectrophotometer. 
 
 
 
 
The absorbance of the solution was taken at 535nm. The spectrophotometer was 
calibrated for 535nm. The baseline absorption at535 nm was 0. Initially the absorption of 
the red dye was taken in a cuvette. Then the capillary tube holder was used. The 
absorption and transmission% was noted for 6 different samples. 
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The same capillary tube was used in the optical cell and the photodiode voltage 
from the lock-in amplifier was noted. 
 
 
 
 
 
Figure 17. Calibration curve of the optical cell. 
 
 
 
 
Table 5.  Tabulation  of  the Absorption  and  transmission% of different  concentration 
sample and their corresponding photodiode output. 
 
Capillary tube  Photodiode Output mV  Average 
in mV 
Absorption Transmission % Trial I Trial II Trial III  
0.694 20.2 4.72  4.79  4.76 4.76 
0.797 16.4  
4.42 
  
4.42 
  
4.49 
 
4.44 
0.83 14.8  
4.25 
  
4.31 
  
4.21 
 
4.26 
0.982 10.4  
3.94 
  
3.96 
  
3.98 
 
3.96 
1.061 8.8  
3.85 
  
3.81 
  
3.83 
 
3.83 
1.215 6.1  
3.61 
  
3.65 
  
3.59 
 
3.62 
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CHAPTER 6 
RESULTS 
 
 
RBC under Microscope 
 
The blood that is smeared on the glass slide is seen under the microscope and 
the images are captured using the QCapture Pro 6 software. The size of the RBC that 
was diluted in the PBS was around 5-5.8 µm. This is considered to be a control for 
comparing the change in size of RBC with the glucose concentration. The image was 
taken after 30 minutes so as the RBC to undergo the osmosis process. 
 
 
 
 
 
Figure 18. RBC diluted in PBS. 
 
Another blood smear made by diluting the blood with 2.5 mM glucose 
concentration was seen under the microscope after 30 minutes. The image shows that the 
RBCs have increased in size to      6.5 µm. 
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Figure 19. RBC diluted in 2.5 mM glucose concentration. 
 
The blood smear diluted with 7.5 mM glucose concentration shows that the RBCs 
have shrunk in size < 4 µm. 
 
 
 
 
 
Figure 20. RBC diluted in 7.5 mM glucose concentration. 
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RBC in cell counter 
 
The initial trial was conducted by diluting the blood by 10000 times in PBS and 
then adding different concentration of glucose to the diluted blood. This sample is then 
scanned in the cell counter. 
 
 
 
Table 6. Cell counter reading of blood diluted in PBS. 
 
Concentration Average diameter of Viable cell in µm 
Trial I Trial II 
PBS 6.4 6.1 
2.5 mM 9.2 9.8 
5 mM 5.8 5.5 
 
 
Final trial was conducted by diluting the blood by 10000 timies in different 
glucose concentration like 2.5 mMol and 5 mMol. 
 
 
 
Table 7. Cell counter reading of blood diluted in different glucose concentration. 
 
Concentration Average diameter of Viable 
 
cell in µm 
PBS 7.6 
2.5 mM 7.4 
5 mM 7.8 
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Optical Cell 
 Tracking of opacity changes at 535nm in a capillary tube of whole rodent blood was 
performed. Glucose concentration changes in the unpreserved blood as a result of 
continuous metabolism of red blood cells. Initial blood glucose measurements were taken at 
the start of the experiment and at the end. This shows the changes in glucose concentration 
with time. Fresh rat blood in a hematocrit tube was introduced into the experimental test 
setup.  Data was captured manually every thirty seconds and plotted using Excel.   
The absorbance values as reflected photo detector output were continuously 
acquired from the output of the lock-in amplifier. 
Figures 22-24 shows the results of these trials. The decrease in absorbance causing 
an increase in light transmittance can be seen on the plots over duration of an hour or till 
saturation is reached. The decrease was calculated as a slope of the line after stabilization.   
The sample was examined visually at the end of the study and showed no evidence 
of coagulation if capped at the end with clay. 
Figure 22 shows the absorbance test reading with 5 mA through the photodiode 
giving a relatively higher response than Figure 23 test where the current was 6 mA and 
hence the scale differences.  
The output of the optical cell is the reading of the photodiode from the Lock-in 
amplifier. 
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Figure 21. Plot of the photodiode output with LED driven at 6V 
 
 
 
 
 
 
 
 
Figure 22. Plot of the photodiode output with LED driven at 5V; Trial I 
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Figure 23. Plot of the photodiode output with LED driven at 5V; Trial II 
 
 
 
 
 
 
 
 
 
Figure 24. Plot of the photodiode output with blood sample delayed for 2 hours 
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Figure 25. Plot of the photodiode output with blood sample with dialyzer fiber to increase 
glucose concentration. 
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CHAPTER 7 
DISCUSSION 
 
The results of this study support the hypothesis that optical absorbance changes at 
535 nM can be used to as an indirect indicator of glucose concentration changes in whole 
blood.   
 
The images under the microscope show that the RBCs change in diameter with 
the glucose concentration in the biological range. The change in their volume is correlated 
to changes in an absorbance cell. The control for the images is the blood diluted with PBS. 
In this slide, the diameter of the RBC varies between 5-5.8 µm. In the slide prepared by 
diluting the blood in 2.5mM glucose concentration, the cell tends to dilate as more 
water molecules enter the RBCs. The size of the RBCs increases up to 6.5µm. When the 
blood was diluted with 5 mM concentration of glucose, the cells started to shrink as the 
water molecule started to move out from the RBCs. 
The cell counter proved the similar results. The average size of the cells where 
noted. Initially the blood sample was diluted 10000 times in PBS as the concentration of 
RBC was high and made it difficult for the cell counter to count. Then glucose solution 
was added to the diluted blood. Later the blood sample was diluted in solution of 
different glucose concentration itself. There were lots of dead cells found when test was 
not done within 30- 60 minutes of the blood extraction from rodent. 
Initial data acquisition from the optical cells had challenges for stability and 
accuracy. LED emitted steady output by the use of constant current source. The 
frequency of the LED to emit light was initially set to 40Hz. Due to electronic noise 
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frequency close to the set frequency; there were fluctuations in the output. Hence the 
frequency was set to 200 Hz. Blood sample tested within 30 minutes of extraction 
showed better results. This was because the blood was fresh and has no coagulation. If 
the blood sample is left for more than 2 hours, it gets coagulated. Also if the heparinized 
tube is capped with the clay at one end, stayed un-coagulated till the end of the test. But it 
was difficult to take the glucose reading of the blood from the capillary tube. As expected 
the voltage increased with time with decreasing glucose concentration. In theory, the 
RBC uses glucose as a fuel and is an anaerobic metabolism. With time the glucose 
concentration decreases due to cell metabolism. 
As the blood is drawn from the rodent, the cell still consumes the glucose in the 
sample, thus decreasing the concentration of the blood glucose. As the glucose 
concentration decreases, the cells dilate due to osmosis. This decreases the absorption 
coefficient, thus increasing the amount of light transmitted. Increasing transmission 
results in increased photodiode output. The changes in absorption is non linear. From the 
calibration curve, the changes in absorption can be calculated. Figure 25 shows the plot 
of the photodiode response to a blood sample that was tested after a 2 hour delay. Here, 
due to coagulation the change in absorption is not seen. 
Attempts were made to increase the glucose concentration in the blood sample 
using the dialyzer fiber without increasing the volume of the sample. There were 
difficulties in getting the dialyzer fiber through the capillary tube with the blood sample. 
The results of the successfully inserted fiber through the capillary tube were not 
repeatable. 
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CHAPTER 8 
CONCLUSION 
 
 
 
The osmolarity phenomenon was tested in the RBC for the glucose concentration 
that is within the normal range of blood glucose. The images showed the changes in size 
of the RBC with different glucose concentration that are within the human blood glucose 
range. These changes were confirmed with the cell counter automatically too. 
The optical cell that was built was able to detect the changes in absorption. But 
the optical cell can be made sophisticated with the use of heat sink and lens for the LED 
to reduce heating effect and focus the light on the capillary tube with less scattered light 
respectively. The photodiode can also be used with amplifier for increased signal output. 
The set up for increasing the glucose concentration was not very successful. This 
method can be improvised and optimized to increase the blood concentration. The 
capillary tube holder used for calibration was used to see the absorption change in the 
blood sample too. But as the absorption was higher than the range of the 
spectrophotometer, it was not able to detect the changes. Hence a spectrophotometer that 
can detect higher range of absorption can be used to detect the absorption changes in the 
blood sample. 
LED was placed on the ear lobe and the photodiode was able to pick up the light 
emitted through the tissues of the ear lobe. The calibration curve is used to find the 
absorption against the voltage value from the photodiode during experiment with the 
same parameters used during calibration. 
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It has been demonstrated that the changes in absorption due to changes in glucose 
concentration can be measured at 540 nm. Though the system is stable, repeatability of 
results depends on the consistent sample conditions like time between extraction of blood 
and the first data acquisition time, storage or transportation conditions, ambient 
temperature and light. 
Though this system is designed only to track the changes in glucose 
concentration, optimizing absorption with the glucose concentration might help in 
detecting the exact concentration of glucose in the blood non-invasively. 
Physiological conditions that might interfere in the readings were not considered 
in this stage of experiment. For later development, physiological conditions that might 
change the absorption of 540 nm wavelength should be considered and the system 
should be optimized for it. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
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APPENDIX A 
 
SYSTEM DEVELOPED FOR INCREASING THE GLUCOSE CONCENTRATION IN 
CAPILLARY TUBE THAT IS TO BE USED IN THE SPECTROPHOTOMETER. 
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Figure 1. Capillary tube with dialyzer fiber holder for spectrophotometer reading. 
 
This layout was 3D printed to be used in the spectrophotometer. A dialyzer fiber 
is introduced into the capillary tube and the end is taken out of the outlet port. The inlet 
of the dialyser fiber is inserted into a needle of a syringe with known glucose 
concentration solution. The syringe is operated by a syringe pump at a constant rate of 
1mL/minute. The speed of the syringe pump can varied depending on the glucose 
concentration and need. 
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Initially the system was tested with a red dye to see if the diffusion works as 
expected. Color of the solution in the capillary tube seems to vary with time, proving the 
diffusion that takes place through the dialyzer fiber. 
Though the system worked, it was not used as the spectrophotometer was not able 
to detect the absorption range. This can be useful if the spectrophotometer is able to 
detect the range. 
 
 
 
Syringe 
Dialyzer 
fiber 
 
 
 
 
 
Syringe 
Pump 
Spectro 
photometer 
 
 
 
 
 
 
 
 
 
 
Figure 2. Experimental set up for increasing glucose concentration in capillary tube that is 
to be used in a spectrophotometer 
